Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
Not Applicable
Recruiting
- Conditions
- ALS - Amyotrophic Lateral Sclerosis
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- PathMaker Neurosystems Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT06649955
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Early Feasibility Study of the MyoRegulator® for Treatment of ALS
Not Applicable
Completed
- Conditions
- Amyotrophic Lateral Sclerosis
- First Posted Date
- 2023-12-11
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- PathMaker Neurosystems Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT06165172
- Locations
- 🇺🇸
Spaulding Rehabilitation Hospital, Charlestown, Massachusetts, United States
Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb Spasticity
Not Applicable
Terminated
- Conditions
- StrokeMuscle Spasticity
- First Posted Date
- 2021-02-08
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- PathMaker Neurosystems Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT04742257
- Locations
- 🇺🇸
Spaulding Rehabilitation Hospital, Charlestown, Massachusetts, United States
News
No news found